Population-based clinic-pathological studies have established that the most common
pathological substrate of dementia in community-dwelling elderly people is mixed …

Background Numerous studies have investigated risk factors for Alzheimer disease (AD).
However, at a recent National Institutes of Health State-of-the-Science Conference, an …

Mild Alzheimer's disease is the leading cause of dementia, accounting for 50–70% of cases.
Alzheimer's disease is an irreversible neurodegenerative disease, which affects daily life …

Since first described in the early 1900s, Alzheimer's disease (AD) has risen exponentially in
prevalence and concern. Research still drives to understand the etiology and pathogenesis …

Abstract Purpose Although Alzheimer disease and related dementias (ADRDs) have long
been considered nonpreventable and even an inevitable consequence of aging, recent …

Due to the progressive aging of the population, Alzheimer's disease (AD) is becoming a
healthcare burden of epidemic proportions for which there is currently no cure …

The global prevalence of dementia is estimated to be as high as 24 million, and is predicted
to double every 20 years through to 2040, leading to a costly burden of disease. Alzheimer …

Alzheimer's disease (AD) affects more than 5 million Americans, with substantial
consequences for individuals with AD, families, and society in terms of morbidity, mortality …

Current research including the basic biology of Alzheimer's disease (AD) provides a
foundation to explore whether our current state of knowledge is sufficient to initiate …

BACKGROUND AND AIMS: Global population aging has been one of the defining
processes of the twentieth century, with profound economic, political and social …